Aripiprazole Oral Solution

Patent No. EP2436384 (titled "Aripiprazole Oral Solution") was filed by Bristol Myers Squibb on Apr 24, 2002. The application was issued on May 23, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETIMar 9, 2016KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2436384

BRISTOL MYERS SQUIBB
Application Number
EP11190103A
Filing Date
Apr 24, 2002
Status
Patent Maintained As Amended
Apr 20, 2018
Publication Date
May 23, 2018